220 related articles for article (PubMed ID: 24531709)
1. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
[TBL] [Abstract][Full Text] [Related]
2. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
[TBL] [Abstract][Full Text] [Related]
3. Mice thrive without Cdk4 and Cdk2.
Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
[TBL] [Abstract][Full Text] [Related]
4. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
[TBL] [Abstract][Full Text] [Related]
5. Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis.
Macias E; Miliani de Marval PL; Senderowicz A; Cullen J; Rodriguez-Puebla ML
Cancer Res; 2008 Jan; 68(1):162-71. PubMed ID: 18172308
[TBL] [Abstract][Full Text] [Related]
6. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
7. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
8. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.
Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK
Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136
[TBL] [Abstract][Full Text] [Related]
10. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
11. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy.
Zhao X; Xu Y; Wu Y; Zhang H; Shi H; Zhu H; Woo M; Wu X
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E135-E144. PubMed ID: 30512986
[TBL] [Abstract][Full Text] [Related]
13. Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.
Lu J; Hamze Z; Bonnavion R; Herath N; Pouponnot C; Assade F; Fontanière S; Bertolino P; Cordier-Bussat M; Zhang CX
Oncogene; 2012 Aug; 31(31):3647-54. PubMed ID: 22120711
[TBL] [Abstract][Full Text] [Related]
14. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
[TBL] [Abstract][Full Text] [Related]
15. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
16. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.
Desai SS; Modali SD; Parekh VI; Kebebew E; Agarwal SK
J Biol Chem; 2014 Feb; 289(9):5386-98. PubMed ID: 24425879
[TBL] [Abstract][Full Text] [Related]
18. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
[TBL] [Abstract][Full Text] [Related]
19. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary.
Jirawatnotai S; Aziyu A; Osmundson EC; Moons DS; Zou X; Kineman RD; Kiyokawa H
J Biol Chem; 2004 Dec; 279(49):51100-6. PubMed ID: 15456744
[TBL] [Abstract][Full Text] [Related]
20. Of mice and MEN1: Insulinomas in a conditional mouse knockout.
Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Mol Cell Biol; 2003 Sep; 23(17):6075-85. PubMed ID: 12917331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]